Eleuthero Root is the Primary Concern for Tachycardia in POTS Patients
Eleuthero root (Eleutherococcus senticosus) at 1000mg poses the highest risk for exacerbating tachycardia in POTS patients and should be avoided. This adaptogenic herb is classified as an herbal stimulant with known cardiovascular effects, including increased heart rate and potential for triggering arrhythmias 1.
Risk Assessment by Ingredient
High Risk: Eleuthero Root
- Mechanism: Eleuthero is an adaptogen with sympathomimetic properties that can increase sympathetic nervous system activity
- Specific concern in POTS: POTS patients already have excessive orthostatic tachycardia (≥30 bpm increase on standing, with standing heart rate ≥90 bpm) 2. Many have hyperadrenergic features with elevated catecholamines
- Evidence: Herbal stimulants are the most common category of herbal therapies to cause cardiovascular effects, including tachycardia and arrhythmias 1
- Dose consideration: The 1000mg dose is substantial and likely to produce physiologic effects
Low to Moderate Risk: Reishi Mushroom Extract
- Mixed evidence: While one study showed reishi had cardioprotective effects in rats 3, another review noted that mushrooms are recognized as arrhythmogenic foods 4
- Concern: The general category of "mushrooms" has been linked to arrhythmias, though specific data on reishi in POTS is lacking 4
- Recommendation: Exercise caution, particularly at the 500mg extract dose
Minimal Risk: Other Ingredients
- Carob pods, chicory root, barley, ramón seed: No documented cardiovascular stimulant effects or tachycardia risk in the literature reviewed
- These are generally considered food-grade ingredients without significant autonomic effects
Clinical Reasoning for POTS Context
POTS pathophysiology involves multiple mechanisms including hyperadrenergic stimulation, autonomic denervation, and hypovolemia 2. The Canadian Cardiovascular Society guidelines emphasize that:
- Treatment aims to reduce sinus tachycardia through medications like beta-blockers (propranolol 10-20mg four times daily) and ivabradine 2
- Patients with hyperadrenergic symptoms may require central sympatholytic agents like clonidine 2
- Any substance that increases sympathetic tone or heart rate directly opposes therapeutic goals
Practical Recommendation
Discontinue the product containing eleuthero root immediately. The combination of a known herbal stimulant at a therapeutic dose (1000mg) in a patient whose condition is defined by excessive tachycardia creates an unacceptable risk-benefit ratio.
Common Pitfall to Avoid
Patients often assume herbal supplements are "natural" and therefore safe 1. However, herbal stimulants can have potent cardiovascular effects and may interact with POTS medications like beta-blockers or ivabradine, potentially reducing their efficacy or causing unpredictable effects.
Monitoring Considerations
If the patient has already been consuming this product, monitor for:
- Worsening orthostatic tachycardia (measure supine and standing heart rates)
- Increased palpitations, tremors, or anxiety (hyperadrenergic symptoms)
- Worsening orthostatic intolerance symptoms (lightheadedness, presyncope)
The reishi mushroom component warrants individual assessment based on symptom response, but eleuthero root is contraindicated in POTS management.